Today: 19 May 2026
Browse Category

LSE:HOC 1 December 2025 - 12 December 2025

Biggest UK Stock Market Gainers Today: 1Spatial Jumps 42% on Takeover Talks, Fresnillo Leads FTSE 100 Risers (12 December 2025)

Biggest UK Stock Market Gainers Today: 1Spatial Jumps 42% on Takeover Talks, Fresnillo Leads FTSE 100 Risers (12 December 2025)

London’s FTSE 100 and FTSE 250 each rose about 0.4% early Friday, despite data showing the UK economy shrank in October and the trade deficit widened. AIM-listed 1Spatial jumped 42% after agreeing in principle to a possible £87.1 million cash takeover by VertiGIS. Hochschild Mining gained 8.2% as silver rallied near record highs.
12 December 2025
···
UK Stock Market Today: FTSE 100 Slips as Risk-Off Mood Starts December in London

UK Stock Market Today: FTSE 100 Slips as Risk-Off Mood Starts December in London

The FTSE 100 slipped 0.1–0.2% to around 9,700 by early afternoon in London on December 1, while the FTSE 250 dropped 0.8%, its sharpest fall in two weeks. Mining stocks climbed over 5% as gold and silver prices rose, but aerospace, defence, and major banks declined. Homebuilders in the FTSE 250 fell more than 1.5% amid concerns over higher borrowing costs and weak services data.
1 December 2025
·······
UK Stock Market Today: FTSE 100 Flat, Mid‑Caps Slide as Risk‑Off Mood Opens December – 1 December 2025

UK Stock Market Today: FTSE 100 Flat, Mid‑Caps Slide as Risk‑Off Mood Opens December – 1 December 2025

The FTSE 100 held near record highs on Monday, trading at 9,718 by early afternoon, down just 0.03%. The FTSE 250 slid 0.8%, its sharpest fall in two weeks, as investors sold off mid-cap and cyclical stocks. Gold miners surged more than 5% as bullion hit a six-week high. Rolls-Royce fell 3%, while HICL Infrastructure rose 4.4%.
1 December 2025
········

Stock Market Today

  • When Will Island Pharmaceuticals Limited (ASX:ILA) Reach Profitability?
    May 19, 2026, 3:26 AM EDT. Island Pharmaceuticals Limited (ASX:ILA), a drug repurposing company focusing on antiviral therapeutics in Australia and the U.S., posted a AU$3.9 million loss in the latest financial year and a AU$7.2 million loss over the trailing twelve months. Analysts project the company will break even in 2027 and reach a profit of AU$295 million by 2028. This forecast implies an ambitious average annual growth rate of 140%. Notably, Island Pharmaceuticals operates with no debt, relying solely on shareholder funding, which reduces financial risk typical in cash-burning pharmaceutical firms. Investors anticipate milestone developments but should remain cautious of the high growth assumptions given the volatile nature of pharmaceutical cash flows during drug development phases.

Latest articles

Nasdaq gives up after-hours gains as oil and yields weigh on Wall Street rally

Nasdaq gives up after-hours gains as oil and yields weigh on Wall Street rally

19 May 2026
Dominion Energy shares jumped 9.4% after agreeing to an all-stock merger with NextEra Energy, whose shares fell 4.6%. The S&P 500 slipped 0.1% and the Nasdaq dropped 0.5% as investors sold technology stocks amid rising Treasury yields and oil prices. Nvidia fell 1.4% ahead of earnings. U.S. crude settled at $107.37, and the 10-year Treasury yield reached 4.59%.
XP Shares Slip Post-Q1, Buyback Fails to Sway Investors

XP Shares Slip Post-Q1, Buyback Fails to Sway Investors

19 May 2026
XP Inc.’s U.S.-listed shares fell 3.78% in after-hours trading Monday after reporting higher Q1 profit but weaker net inflows and a lower retail take rate. Net income rose 7% to 1.32 billion reais, but net inflow dropped to 14 billion reais from 24 billion a year earlier. The company declared a $0.20 dividend and announced a new CFO, Gustavo Alejo Viviani, starting August 3.
LiveRamp Rallies 27% After Publicis $2.5 Billion Cash Bid

LiveRamp Rallies 27% After Publicis $2.5 Billion Cash Bid

19 May 2026
Publicis Groupe agreed to buy LiveRamp Holdings for $38.50 a share in cash, valuing the U.S. data-collaboration firm at $2.546 billion. LiveRamp stock jumped to $37.77 on the news, while the broader market fell. LiveRamp reported fiscal Q4 revenue of $206 million, up 9% from a year earlier. Publicis said the deal will boost its adjusted earnings per share from the first year after closing.

Popular

Destiny Tech100 Gains Pre-Market as SpaceX IPO Buzz Mixes With AI Stock Warnings

Destiny Tech100 Gains Pre-Market as SpaceX IPO Buzz Mixes With AI Stock Warnings

18 May 2026
Destiny Tech100 Inc. shares rose 10.6% to $52.68 in early premarket trading Monday after reports that SpaceX may list on Nasdaq as soon as June 12 at a $1.75 trillion valuation. DXYZ’s portfolio includes about 14.4% exposure to SpaceX and 18.1% to Anthropic. The stock ended last week down 13% despite sharp swings. Destiny’s shares last closed at nearly double their reported net asset value.
Go toTop